Seregno, Italy

Giuseppe Colombo

This inventor holds 1 USPTO granted patent, plus 2 CIPO patents and 3 EPO patents. Top assignee: Italfarmaco Spa. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giuseppe Colombo. Retrieved from https://idiyas.com/inventor/giuseppe-colombo-up046jz0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Giuseppe Colombo: Inventor of a Stable Givinostat Oral Suspension

Introduction

Giuseppe Colombo is an inventor associated with Seregno, Italy. His patent work concerns a stable oral formulation of givinostat, a pharmaceutical compound intended for systemic therapeutic use.

Latest Patents

The supplied information lists one patent for Colombo: “Physically and chemically stable oral suspensions of givinostat.” The invention describes aqueous oral suspensions containing givinostat, or pharmaceutically acceptable salts or derivatives, together with at least one wetting agent and/or density-imparting agent. It also discloses methods for preparing these formulations, which are designed to remain physically and chemically stable and to support oral administration.

Colombo is credited with 1 patent in the information provided.

Career Highlights

Colombo’s listed company affiliations include Italfarmaco S.p.A. and Pharmacia & Upjohn Company. The available details connect his patent activity with pharmaceutical formulation and the development of oral medicines.

Collaborations

The supplied information names Maria Valmen Monzani and Silvia Puccianti as Colombo’s coworkers. Their specific roles in the patent or related work are not provided.

Conclusion

Giuseppe Colombo’s documented invention focuses on a stable oral suspension of givinostat, reflecting a contribution to pharmaceutical formulation and oral drug delivery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…